10.30 am Melbourne time.
LBS.06 - Late Breaking Science in Coronary RevascularizationWhen: Sunday, November 11, 2018, 5:30 p.m.– 6:45 p.m.
Where: Main Event II (s100)
- REGROUP
Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial With Long-Term Follow-up
- FREEDOM Follow-On Study
Long-term Survival following Multivessel Revascularization in Patients with Diabetes: the FREEDOM Follow-On Study
- TiCAB
A Randomized, Double-blind Study Of Ticagrelor Versus Aspirin In Patients Undergoing Coronary Bypass Surgery
- ISAR TEST 4
Ten-Year Clinical Outcomes After Coronary Drug-Eluting Stents with Biodegradable or Permanent Polymer Coating: Results from the Randomized ISAR-TEST 4 Trial
- Intramyocardial Injection of Mesenchymal Precursor Cells in Left Ventricular Assist Device Recipients: Impact on Myocardial Recovery and Morbidity
- Forums
- ASX - By Stock
- MSB
- AHA conference details
AHA conference details
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18877 | 92.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 6795 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18877 | 0.920 |
4 | 57615 | 0.915 |
4 | 170707 | 0.910 |
5 | 132198 | 0.905 |
6 | 205763 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
0.925 | 6795 | 1 |
0.930 | 37503 | 3 |
0.935 | 49349 | 3 |
0.940 | 161756 | 6 |
0.945 | 29349 | 1 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
MSB (ASX) Chart |